TP53 and neoplasm: Decreases histone deacetylases’ expression and inhibits their activity (HDAC3, -6, -7, and -8). Induces p53, activates caspase 3, anddecreases antiapoptotic Bcl-2 and Mcl-1 in tumor tissues.